Titan Pharmaceuticals Inc.

TTNP | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.34

$0.00 (0.00%)

Nov 2, 2026, 3:14 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Sep 30, 2026

19.2

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $3.11M

1D Range

2.30 2.69

52W Range

2.33 15.15

Valuation (TTM)

PE -0.01

PB 2.00

EV/EBITDA -1.14

Valuation (NTM)

Forward PE 0.13

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -109.7%

SBC Adj. FCF Yield -109.7%

SBC Impact N/A

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y -142.3% | -81.2%

Dil EPS 3Y | 5Y -143.3% | -92.7%

FCF 3Y | 5Y 38.4% | 21.8%

Returns

ROA -45.7%

ROE -91.1%

ROIC -121.0%

Financial Health

Net Cash

$328K

Current Ratio 1.40

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Titan Pharmaceuticals, Inc. is a pharmaceutical company dedicated to creating treatments for chronic conditions, with its product development centered around ProNeura, a unique platform designed for e...

Sector Healthcare

Industry Biotechnology

Employees 4

IPO Date Jan 18, 1996

Website www.titanpharm.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.